Search

everythinglearnresearchcommunity

for

Search:↓

Treating sleep apnea in young obese women with PCOS can improve heart health and insulin sensitivity.

Male hormones and their receptors play a key role in hair loss and skin health, with potential new treatments being explored.

Obesity increases the risk of developing polycystic ovary syndrome, and weight loss can improve the condition.

PCOS is a common hormonal disorder in women, marked by symptoms like hair growth and menstrual issues, and requires personalized treatment.

Women with PCOS who have low SHBG are more likely to have low good cholesterol and metabolic syndrome.

Metabolic syndrome and PCOS are related but separate conditions, with metabolic syndrome increasing the risk of heart disease and diabetes.

People with polycystic ovary syndrome have a higher chance of having chronic thyroiditis.

Androgens play a complex role in skin conditions like acne and hair loss in women, and normal blood levels don't always show true androgen status.

Different types of PCOS have different levels of metabolic problems, with the most severe type showing the highest disturbances.

About 13% of women had idiopathic hirsutism and 8.5% had polycystic ovary syndrome in a group of Iranian women.

Certain microRNAs in the fluid around eggs are linked to Polycystic Ovary Syndrome and may help diagnose it.

Women with PCOS are more likely to have insulin resistance and obesity, especially those with the most severe type I PCOS.

About 8.5% of women in Salvador, Brazil, have Polycystic Ovary Syndrome.

Female hair loss linked to metabolic syndrome, not in males.

Women with PCOS have a higher risk of diabetes, heart problems, certain cancers, and mental health issues, but early treatment can help manage these risks.

More PDCD4 is linked to obesity, insulin problems, and cell death in ovaries for those with polycystic ovary syndrome.

High afamin levels are linked to metabolic syndrome and may predict its development in women with insulin resistance.

Brazilian women with PCOS and both menstrual irregularity and high male hormone levels have a higher chance of having metabolic syndrome.

The study suggests that being overweight or obese, not PCOS itself, is strongly linked to insulin resistance.

The study concluded that both anti-Mullerian hormone and LH/FSH ratio are higher in women with PCOS and combining these markers with BMI could improve diagnosis accuracy.

Young women with PCOS have a higher risk of high blood pressure and metabolic syndrome, but these risks may decrease after age 40.

The research found different metabolism changes in PCOS patients and suggested new potential markers for diagnosing PCOS with or without insulin resistance.

A team approach is crucial for managing PCOS, with dermatologists playing a key role.

South Asian women with PCOS present with different symptoms compared to White women, influenced by ethnicity, obesity, and age.

Testosterone therapy can improve sexual desire and function in postmenopausal women but should be used cautiously and not based solely on testosterone levels.

The PCOSQ-50 is a valid and reliable questionnaire for measuring quality of life in Iranian women with PCOS.

Menopausal women have higher androgen levels, which can cause symptoms like facial hair growth and low sexual desire.

Teens with PCOS and a mom with PCOS have higher insulin resistance and lower adiponectin levels, which could signal early metabolic problems.

Women with PCOS have a higher risk of severe COVID-19 due to related health issues.

The combination therapy improved PCOS symptoms in both obese and non-obese women, with weight loss in the obese group.